Perioperative landiolol hydrochloride for preventing of atrial fibrillation after lung resection

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
INTERVENTION: Intravenous prasebo, Glucose 5% during operation. Intravenous landiolol hydrochloride during the operation. CONDITION: lung cancer PRIMARY OUTCOME: the frequency of atrial fibrillation INCLUSION CRITERIA: patients who have lung cancer, to be treated by pnemonectomy or bilbectomy.
Epistemonikos ID: 0eae38e118c26971a5108531733bbf0ae9be7aa1
First added on: Aug 22, 2024